{"id":"W4406687500","doi":"10.1093/ecco-jcc/jjae190.0894","title":"P0720 Cost-effectiveness of vedolizumab vs. ustekinumab as first-line biologic in treatment sequencing for ulcerative colitis in Canada","year":2025,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Medicine; Ustekinumab; Ulcerative colitis; Internal medicine; Gastroenterology; Crohn's disease; Tofacitinib; Dermatology; Infliximab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057152,0.0001578902,0.0007331385,0.0001746908,0.00006304794,0.0000107843,0.0001040104,0.000173471,0.00005745907],"category_scores_gemma":[0.0002345744,0.0001157868,0.0001024198,0.0002013958,0.0001363359,0.00004829912,0.00003077249,0.0001884888,2.193939e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001385181,"about_ca_system_score_gemma":0.001673244,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2029479,"about_ca_topic_score_gemma":0.5454446,"domain_scores_codex":[0.9984866,0.0004295057,0.0005903072,0.0001714307,0.00003434326,0.000287836],"domain_scores_gemma":[0.9983385,0.001143049,0.0002212742,0.0000868518,0.0001765018,0.00003384506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2071073,0.00206128,0.14719,0.002979015,0.004156795,0.002298937,0.002237719,0.001058318,0.01328155,0.05720662,0.002660389,0.557762],"study_design_scores_gemma":[0.009177616,0.002812108,0.9083574,0.001061188,0.0001289915,0.000223091,0.0008655465,0.00008125477,0.05693344,0.005824752,0.01432341,0.0002111658],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952066,0.002229387,0.0002602961,0.0005930017,0.000383069,0.0006416789,0.0001567331,0.000002022311,0.0005271925],"genre_scores_gemma":[0.9984452,0.0008956652,0.0001865158,0.0001959498,0.00001685073,0.00004121715,0.000005900344,0.00000492876,0.0002078227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7611674,"threshold_uncertainty_score":0.8023597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03199449956713621,"score_gpt":0.3149365162590643,"score_spread":0.2829420166919281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}